Identifying NK cell subset best suited for targeting of high grade serous ovarian cancer

鉴定最适合靶向高级别浆液性卵巢癌的 NK 细胞亚群

• 批准号: 449651
• 负责人: Grantham Stephanie R
• 金额: $ 1.27万
• 依托单位: Dalhousie University (Nova Scotia)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-12-01 至 2021-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=449651&lang=en
• 关键词: Immunogenetics; Immunotherapy; Natural Killer Cell; Ovarian Cancer

Immunotherapy is an approach to cancer treatment that harnesses the immune system to eliminate malignant cancer cells. One cancer that could potentially utilize this approach ovarian cancer. Currently, less than fifty percent of live more than five years

免疫疗法是一种利用免疫系统消除恶性癌细胞的癌症治疗方法。一种可能利用这种方法的癌症是卵巢癌。目前，只有不到百分之五十的人能活五年以上。